Annual Current Liabilities
$205.56 M
-$18.03 M-8.06%
31 December 2023
Summary:
Beam Therapeutics annual total current liabilities is currently $205.56 million, with the most recent change of -$18.03 million (-8.06%) on 31 December 2023. During the last 3 years, it has risen by +$103.23 million (+100.87%). BEAM annual current liabilities is now -8.06% below its all-time high of $223.59 million, reached on 31 December 2022.BEAM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$166.24 M
-$11.09 M-6.25%
30 September 2024
Summary:
Beam Therapeutics quarterly total current liabilities is currently $166.24 million, with the most recent change of -$11.09 million (-6.25%) on 30 September 2024. Over the past year, it has dropped by -$54.12 million (-24.56%). BEAM quarterly current liabilities is now -30.40% below its all-time high of $238.86 million, reached on 30 September 2022.BEAM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.1% | -24.6% |
| 3 y3 years | +100.9% | +64.0% |
| 5 y5 years | +703.4% | +735.0% |
BEAM Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.1% | +100.9% | -30.4% | +64.0% |
| 5 y | 5 years | -8.1% | +703.4% | -30.4% | +735.0% |
| alltime | all time | -8.1% | +3031.2% | -30.4% | +985.9% |
Beam Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $166.24 M(-6.3%) |
| June 2024 | - | $177.33 M(-5.3%) |
| Mar 2024 | - | $187.22 M(-8.9%) |
| Dec 2023 | $205.56 M(-8.1%) | $205.56 M(-6.7%) |
| Sept 2023 | - | $220.37 M(+5.2%) |
| June 2023 | - | $209.54 M(-4.7%) |
| Mar 2023 | - | $219.93 M(-1.6%) |
| Dec 2022 | $223.59 M(+4.8%) | $223.59 M(-6.4%) |
| Sept 2022 | - | $238.86 M(+12.5%) |
| June 2022 | - | $212.28 M(-3.0%) |
| Mar 2022 | - | $218.80 M(+2.5%) |
| Dec 2021 | $213.44 M | $213.44 M(+110.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $101.39 M(-21.2%) |
| June 2021 | - | $128.72 M(+26.1%) |
| Mar 2021 | - | $102.09 M(-0.2%) |
| Dec 2020 | $102.34 M(+251.2%) | $102.34 M(+115.7%) |
| Sept 2020 | - | $47.45 M(+21.8%) |
| June 2020 | - | $38.95 M(+23.9%) |
| Mar 2020 | - | $31.44 M(+7.9%) |
| Dec 2019 | $29.14 M(+13.9%) | $29.14 M(+46.4%) |
| Sept 2019 | - | $19.91 M(+30.0%) |
| June 2019 | - | $15.31 M(-40.2%) |
| Dec 2018 | $25.59 M(+289.7%) | $25.59 M |
| Dec 2017 | $6.57 M | - |
FAQ
- What is Beam Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Beam Therapeutics?
- What is Beam Therapeutics annual current liabilities year-on-year change?
- What is Beam Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Beam Therapeutics?
- What is Beam Therapeutics quarterly current liabilities year-on-year change?
What is Beam Therapeutics annual total current liabilities?
The current annual current liabilities of BEAM is $205.56 M
What is the all time high annual current liabilities for Beam Therapeutics?
Beam Therapeutics all-time high annual total current liabilities is $223.59 M
What is Beam Therapeutics annual current liabilities year-on-year change?
Over the past year, BEAM annual total current liabilities has changed by -$18.03 M (-8.06%)
What is Beam Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of BEAM is $166.24 M
What is the all time high quarterly current liabilities for Beam Therapeutics?
Beam Therapeutics all-time high quarterly total current liabilities is $238.86 M
What is Beam Therapeutics quarterly current liabilities year-on-year change?
Over the past year, BEAM quarterly total current liabilities has changed by -$54.12 M (-24.56%)